BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borghini R, Caronna R, Corazziari ES, Picarelli A. Further improvement after 24-month treatment with teduglutide in a patient with active Crohn's disease and short bowel syndrome. Turk J Gastroenterol 2018;29:250-1. [PMID: 29749341 DOI: 10.5152/tjg.2018.17596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Borghini R, Caronna R, Donato G, Picarelli A. GLP-2 analog Teduglutide in active Crohn's disease and short bowel syndrome: Confirmation of anti-inflammatory role and future perspectives. Dig Liver Dis 2020;52:686-7. [PMID: 32340888 DOI: 10.1016/j.dld.2020.03.019] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Privitera G, Pugliese D, Lopetuso LR, Scaldaferri F, Papa A, Rapaccini GL, Gasbarrini A, Armuzzi A. Orphan patients with inflammatory bowel disease - when we treat beyond evidence. World J Gastroenterol 2021; 27(47): 8047-8057 [DOI: 10.3748/wjg.v27.i47.8047] [Reference Citation Analysis]
3 Borghini R, Villanacci V, Oberti A, Caronna R, Trecca A. Long-term Effects of Teduglutide on Intestinal Mucosa in a Patient With Crohn's Disease and Short Bowel Syndrome: Clinical, Endoscopic and Histological Data Compared. Inflamm Bowel Dis 2021:izab171. [PMID: 34255043 DOI: 10.1093/ibd/izab171] [Reference Citation Analysis]